Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2024, 6(2); doi: 10.25236/IJFM.2024.060202.

Advances in the Use of Butorphanol Tartrate in Postoperative Analgesia after Cesarean Section

Author(s)

Zeng Jingzheng, Huang Qingqing, Rao Yunju, Gong Gu

Corresponding Author:
Gong Gu
Affiliation(s)

Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu, China

Abstract

As an agonist-antagonist opioid with good analgesic effect and few side effects, butorphanol tartrate has been widely used as a postoperative analgesic in clinical practice, and its special affinity for κ-opioid receptors makes Butorphanol particularly effective in postoperative analgesia after caesarean section. Meanwhile, with its unique characteristics, Butorphanol tartrate can be stably paired with other drugs alone or in combination with other drugs, and applied to post-cesarean section patients through different modes of administration to produce safe and highly effective analgesia and help the mothers to recover quickly after the operation.

Keywords

Butorphanol tartrate; Cesarean section; Analgesia

Cite This Paper

Zeng Jingzheng, Huang Qingqing, Rao Yunju, Gong Gu. Advances in the Use of Butorphanol Tartrate in Postoperative Analgesia after Cesarean Section. International Journal of Frontiers in Medicine (2024), Vol. 6, Issue 2: 9-15. https://doi.org/10.25236/IJFM.2024.060202.

References

[1] Eisenach JC, Pan PH, Smiley R, et al. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression[J]. Pain, 2008, 140(1): 87-94. 

[2] Li HT, Hellerstein S, Zhou YB, et al. Trends in cesarean delivery rates in China, 2008-2018[J]. JAMA, 2020 Jan 7, 323(1): 89-91.

[3] QIN Chunyu, FENG Xuewei, WANG Chengrong, et al. Effectiveness and safety of opioids for postoperative analgesia after caesarean section[J]. Journal of Clinical Pharmacotherapy, 2020, 18(11): 67-71.

[4] Lavand'homme P. Postcesarean analgesia: effective strategies and association with chronic pain[J]. Curr Opin Anaesthesiol, 2006, 19(3): 244-248.

[5] Dualé C, Frey C, Bolandard F, et al. Epidural versus intrathecal morphine for postoperative analgesia after Caesarean section[J]. Br J Anaesth, 2003, 91(5): 690–694.

[6] Loane H, Preston R, Douglas MJ, et al. A randomized controlled trial comparing intrathecal morphine with transversus abdominis plane block for post-cesarean delivery analgesia[J]. Int J Obstet Anesth, 2012, 21(2): 112–118. 

[7] Wang Y, Fang X, Liu C, et al. Impact of intraoperative infusion and postoperative PCIA of dexmedetomidine on early breastfeeding after elective cesarean section:a randomized double-blind controlled trial[J]. Drug Des Devel Ther, 2020, 14: 1083-1093. 

[8] Kainu JP, Halmesmäki E, Korttila KT, et al. Persistent pain after cesarean delivery and vaginal delivery: a prospective cohort study[J]. Anesth Analg, 2016, 123(6): 1535–1545.

[9] Eisenach JC, Pan PH, Smiley R, et al. Severity of acute pain after childbirth, but not type of delivery,predicts persistent pain and postpartum depression[J]. Pain, 2008, 140(1): 87–94. 

[10] Bollag L, Lim G, Sultan P, et al. Society for obstetric anesthesia and perinatology: consensus statement and recommendations for enhanced recovery after cesarean[J]. Anesth Analg, 2021, 132(5): 1362-1377.

[11] Liu ZQ, Du WJ, Yao SL. Enhanced recovery after cesarean delivery: a challenge for anesthesiologists [J]. Chin Med J (Engl), 2020, 133(5): 590-596.

[12] No authors listed. LiverTox: clinical and research information on drug-induced liver injury [DB/OL]. National Institute of Diabetes and Digestive and Kidney Diseases, 2012.

[13] Commiskey S, Fan LW, Ho IK, et al. Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors[J]. J Pharmacol Sci, 2005, 98(2): 109-116.

[14] Ji J, Lin W, Vrudhula A, et al. Molecular interaction between butorphanol and κ-opioid receptor[J]. Anesth Analg, 2020, 131(3): 935-942. 

[15] Ide S, Minami M, Ishihara K, et al. Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice [J]. Neuropharmacology, 2008, 54(8): 1182-1188.

[16] Grechko OY, Litvinov RA, Spasov AA, et al. Study of μ- and δ-opioid activities in agents with various κ-receptor selectivity[J]. Bull Exp Biol Med, 2017, 162(5): 632-635.

[17] Zhu Z, Zhang W. Efficacy and safety of butorphanol use in patient-controlled analgesia:a meta-analysis[J]. Evid Based Complement Alternat Med, 2021, 2021: 5530441.

[18] Lv S, Sun D, Li J, et al. Anesthetic effect of different doses of butorphanol in patients undergoing gastroscopy and colonoscopy[J]. BMC Surg, 2021, 21(1): 266.

[19] Zhu X, Chen L, Zheng S, et al. Comparison of ED95 of butorphanol and sufentanil for gastrointestinal endoscopy sedation: a randomized controlled trial[J]. BMC Anesthesiol, 2020, 20(1): 101.

[20] Hassan SS, Ahmed A, Rai M, et al. Analgesic efficacy of tramadol and butorphanol in mandibular third molar surgery: a comparative study[J]. J Contemp Dent Pract, 2012, 13(3): 364-370.

[21] LU Ruibin, XU Xudong. Clinical observation of propofol and butorphanol in painless abortion[J]. Journal of Clinical Anaesthesiology, 2009, 25(7): 625-626.

[22] Du J, Li JW, Jin J, et al. Intraoperative and postoperative infusion of dexmedetomidine combined with intravenous butorphanol patient-controlled analgesia following total hysterectomy under laparoscopy[J]. Exp Ther Med, 2018, 16(5): 4063-4069. 

[23] Zhou WG. Observation of the clinical effect of Butorphanol tartrate for intravenous self-controlled analgesia after orthopaedic surgery[J]. Jiangxi Medicine, 2022, 57(3): 267-269.

[24] Kumar A, Kumar R, Verma VK, et al. A randomized controlled study between fentanyl and Butorphanol with low dose intrathecal bupivacaine to facilitate early postoperative ambulation in urological procedures[J]. Anesth Essays Res, 2016, 10(3): 508-511.

[25] Gupta R, Arora D, Kaur S, et al. Comparative study of hemodynamic effects of intrathecal bupivacaine with butorphanol in cardiac and non-cardiac patients[J]. J Anaesthesiol Clin Pharmacol, 2020, 36(4): 511-517.

[26] Sharma A, Kumari A, Gupta R, et al. Comparison of intrathecal bupivacaine-fentanyl and bupivacaine-butorphanol combinations for joint replacement surgeries[J]. J Anaesthesiol Clin Pharmacol, 2022, 38(1): 79-83.

[27] Kaur M, Katyal S, Kathuria S, et al. A comparative evaluation of intrathecal bupivacaine alone, sufentanil or butorphanol in combination with bupivacaine for endoscopic urological surgery[J]. Saudi J Anaesth, 2011, 5(2): 202-207. 

[28] Parikh GP, Veena SR, Vora K, et al. Comparison of epidural butorphanol versus epidural morphine in postoperative pain relief[J]. Middle East J Anaesthesiol, 2014, 22(4): 371-376.

[29] Swathi N, Ashwini N, Shukla MI. Comparative study of epidural bupivacaine with butorphanol and bupivacaine with tramadol for postoperative pain relief in abdominal surgeries[J]. Anesth Essays Res, 2016, 10(3): 462-467.

[30] Kaur J, Bajwa SJ. Comparison of epidural butorphanol and fentanyl as adjuvants in the lower abdominal surgery: A randomized clinical study[J]. Saudi J Anaesth, 2014, 8(2): 167-171.

[31] Gillis JC, Benfield P, Goa KL. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management[J]. Drugs, 1995, 50(1): 157-175.

[32] Davis GA, Rudy AIa, Archer SM, et al. Bioavailability of intranasal butorphanol administered from a single-dose sprayer[J]. Am J Health Syst Pharm, 2005, 62(1): 48-53.

[33] Davis GA, Rudy AC, Archer SM, et al. Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer[J]. Am J Health Syst Pharm, 2004, 61(3): 261-266.

[34] Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults[J]. Acta Anaesthesiol Scand, 2002, 46(7): 759-770. 

[35] Zhao Yuqing, Li Fang, Zhao Yunbo, et al. Clinical efficacy of butorphanol tartrate nasal spray in the treatment of 252 patients with cancer pain[J]. China Cancer Clinics, 2009, 36(9): 497-499.

[36] Wermeling DP, Grant GM, Lee A, et al. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized,double-blind,placebo-controlled,parallel-group study[J]. Clin Ther, 2005, 27(4): 430-440.

[37] Merchant Y P, Halli R, Mograwala H. Comparative evaluation of intranasal butorphanol and oral diclofenac sodium for analgesia after surgical removal of impacted mandibular third molars: split-mouth prospective controlled clinical study[J]. J Maxillofac Oral Surg, 2019, 18(3): 395-399.

[38] Ai Q, Hu YP, Wang YJ, et al. Application of Butorphanol nasal spray in fibreoptic bronchoscopy[J]. Journal of Practical Medicine, 2009, 25(21): 3681-3682.

[39] Chu C C, Chen J Y, Chen C S, et al. The efficacy and safety of transnasal butorphanol for postoperative pain control following lower laparoscopic surgery[J]. Acta Anaesthesiol Taiwan, 2004, 42(4): 203-207.

[40] Zhang Xue, Chi Xiaohui, Tian Xueguang, et al. Clinical observation of Butorphanol tartrate nasal spray for postoperative analgesia in gynaecology[J]. Journal of Clinical Anaesthesiology, 2010, 26(5): 452-453.

[41] Hsu HW, Cheng YJ, Chen LK, et al. Differential analgesic effect of tenoxicam on the wound pain and uterine cramping pain after cesarean section[J]. Clin J Pain, 2003, 19(1): 55-58.

[42] Davis MP. Drug management of visceral pain:concepts from basic research[J]. Pain Res Treat, 2012, 2012: 265605. 

[43] Wang Yueling, Ma Wenjuan, Yang Yong, et al. Effects of intrathecal injection of bupropion mixed with ketamine on cAMP-PKA-CREB signal transduction pathway in the dorsal horn of spinal cord of rats with inflammatory pain[J]. Chinese Journal of Anaesthesiology, 2009, 29(8): 712-715.

[44] Miller PL, Ernst AA. Sex differences in analgesia:a randomized trial of mu versus kappa opioid agonists[J]. South Med J, 2004, 97(1): 35-41.

[45] Liu Yusheng, Wang Wei, Cao Yan, et al. Clinical study of bupropion combined with flurbiprofenate for postoperative analgesia after caesarean section[J]. Journal of Clinical Anaesthesiology, 2013, 29(2): 113-116.

[46] Liu H, Wang Y, Li F, et al. Analgesic and sedative effects of different doses of dexmedetomidine combined with butorphanol in continuous analgesia after a cesarean section[J]. Front Surg, 2022, 9: 896536.

[47] Wang Chaohui, Mao Mao, Zhang Panpan, et al. Effect of continuous background infusion of different doses of butorphanol tartrate on postoperative pain after repeat caesarean section in women with scarred uterus[J]. Journal of Clinical Anaesthesiology, 2020, 36(7): 656-659.

[48] Cai Q, Gong H, Fan M, et al. The analgesic effect of tramadol combined with butorphanol on uterine cramping pain after repeat caesarean section: a randomized, controlled, double-blind study[J]. J Anesth, 2020, 34(6): 825-833.

[49] Mo X, Zhao T, Chen J, et al. Programmed intermittent epidural bolus in comparison with continuous epidural infusion for uterine contraction pain relief after cesarean section: a randomized, double-blind clinical trial[J]. Drug Des Devel Ther, 2022, 16: 999-1009.

[50] Palacios QT, Jones MM, Hawkins JL, et al. Post-caesarean section analgesia: a comparison of epidural butorphanol and morphine[J]. Can J Anaesth, 1991, 38(1): 24-30.

[51] Pokharel K, Rahman TR, Singh SN, et al. The efficacy and safety of low dose epidural butorphanol on postoperative analgesia following cesarean delivery[J]. JNMA J Nepal Med Assoc, 2008, 47(170): 57-61.

[52] Hu YM, Kong MJ. Butorphanol for epidural analgesia after caesarean section[J]. Journal of Clinical Anaesthesiology, 2007, 23(8): 691-692.

[53] Shankar K A, Puri R, Goel JK. Butorphanol-bupivacaine versus fentanyl-bupivacaine for extradural analgesia during labour[J]. Med J Armed Forces India, 2006, 62(3): 224-227. 

[54] Escarment J, Clément HJ. Emploi des opiacés par voie périmédullaire en obstétrique. Use of epidural and intrathecal opiates in obstetrics[J]. Ann Fr Anesth Reanim, 1989, 8(6): 636-649. French.

[55] Abbi P, Gupta R, Kaur H, et al. Comparing duration of analgesia after intrathecal administration of opioids in primary paturients for lower segment cesarean section[J]. Anesth Essays Res, 2021, 15(3): 327-331.

[56] Abboud TK, Zhu J, Gangolly J, et al. Transnasal butorphanol: a new method for pain relief in post-cesarean section pain[J]. Acta Anaesthesiol Scand, 1991, 35(1): 14-18.

[57] Shang Yu, Gu Peifi. Observation on the anaesthetic effect of propofol reinforced by Butorphanol nasal spray on painless abortion[J]. Journal of Clinical Anaesthesiology, 2008, 24(11): 1000-1001.

[58] Du Jing, Sun Chuanliang. Effectiveness of butorphanol nasal drops for analgesia in women undergoing first caesarean section[J]. Journal of Clinical Anaesthesiology, 2021, 37(9): 977-978.